vs

Side-by-side financial comparison of Creative Media & Community Trust Corp (CMCT) and PRECISION BIOSCIENCES INC (DTIL). Click either name above to swap in a different company.

PRECISION BIOSCIENCES INC is the larger business by last-quarter revenue ($34.2M vs $28.5M, roughly 1.2× Creative Media & Community Trust Corp). PRECISION BIOSCIENCES INC runs the higher net margin — 58.9% vs -125.8%, a 184.6% gap on every dollar of revenue. On growth, PRECISION BIOSCIENCES INC posted the faster year-over-year revenue change (5261.1% vs 3.6%). Over the past eight quarters, PRECISION BIOSCIENCES INC's revenue compounded faster (39.5% CAGR vs -8.5%).

Creative Media & Community Trust Corp is a U.S.-headquartered real estate investment trust operating two core segments: it owns, manages and develops creative media facilities including professional film and TV production studios, plus community-focused assets such as affordable housing, neighborhood healthcare centers and local commercial spaces, serving media operators and local communities nationwide.

Precision BioSciences, Inc. is a publicly traded American clinical stage gene editing company headquartered in Durham, North Carolina. Founded in 2006, Precision is focused on developing both in vivo and ex vivo gene editing therapies using its proprietary "ARCUS" genome editing platform.

CMCT vs DTIL — Head-to-Head

Bigger by revenue
DTIL
DTIL
1.2× larger
DTIL
$34.2M
$28.5M
CMCT
Growing faster (revenue YoY)
DTIL
DTIL
+5257.5% gap
DTIL
5261.1%
3.6%
CMCT
Higher net margin
DTIL
DTIL
184.6% more per $
DTIL
58.9%
-125.8%
CMCT
Faster 2-yr revenue CAGR
DTIL
DTIL
Annualised
DTIL
39.5%
-8.5%
CMCT

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CMCT
CMCT
DTIL
DTIL
Revenue
$28.5M
$34.2M
Net Profit
$-11.4M
$20.1M
Gross Margin
Operating Margin
-125.6%
36.6%
Net Margin
-125.8%
58.9%
Revenue YoY
3.6%
5261.1%
Net Profit YoY
-11.4%
213.5%
EPS (diluted)
$-3.89
$2.62

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CMCT
CMCT
DTIL
DTIL
Q4 25
$28.5M
$34.2M
Q3 25
$26.2M
$13.0K
Q2 25
$29.7M
$18.0K
Q1 25
$32.3M
$29.0K
Q4 24
$27.5M
$638.0K
Q3 24
$28.6M
$576.0K
Q2 24
$34.4M
$49.9M
Q1 24
$34.0M
$17.6M
Net Profit
CMCT
CMCT
DTIL
DTIL
Q4 25
$-11.4M
$20.1M
Q3 25
$-12.5M
$-21.8M
Q2 25
$-9.0M
$-23.5M
Q1 25
$-6.1M
$-20.6M
Q4 24
$-10.3M
Q3 24
$-10.4M
$-16.4M
Q2 24
$-796.0K
$32.7M
Q1 24
$-3.7M
$8.6M
Operating Margin
CMCT
CMCT
DTIL
DTIL
Q4 25
-125.6%
36.6%
Q3 25
-47.7%
-158976.9%
Q2 25
-30.3%
-121538.9%
Q1 25
-19.0%
-76248.3%
Q4 24
-128.8%
Q3 24
-36.9%
-3693.6%
Q2 24
-1.6%
48.4%
Q1 24
-10.7%
-23.8%
Net Margin
CMCT
CMCT
DTIL
DTIL
Q4 25
-125.8%
58.9%
Q3 25
-47.5%
-167476.9%
Q2 25
-30.3%
-130666.7%
Q1 25
-18.9%
-70913.8%
Q4 24
-129.8%
Q3 24
-36.3%
-2851.6%
Q2 24
-2.3%
65.6%
Q1 24
-11.0%
48.8%
EPS (diluted)
CMCT
CMCT
DTIL
DTIL
Q4 25
$-3.89
$2.62
Q3 25
$-23.52
$-1.84
Q2 25
$-18.94
$-2.13
Q1 25
$-20.73
$-2.21
Q4 24
$97.71
Q3 24
$-305.04
$-2.25
Q2 24
$-98.64
$4.67
Q1 24
$-125.46
$1.70

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CMCT
CMCT
DTIL
DTIL
Cash + ST InvestmentsLiquidity on hand
$15.4M
$115.6M
Total DebtLower is stronger
$509.8M
Stockholders' EquityBook value
$265.4M
$92.2M
Total Assets
$859.2M
$154.4M
Debt / EquityLower = less leverage
1.92×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CMCT
CMCT
DTIL
DTIL
Q4 25
$15.4M
$115.6M
Q3 25
$17.3M
$44.9M
Q2 25
$27.8M
$62.2M
Q1 25
$19.8M
$77.2M
Q4 24
$20.3M
$86.3M
Q3 24
$18.5M
$101.2M
Q2 24
$29.3M
$123.6M
Q1 24
$21.3M
$137.8M
Total Debt
CMCT
CMCT
DTIL
DTIL
Q4 25
$509.8M
Q3 25
$527.8M
Q2 25
$535.6M
Q1 25
$512.7M
Q4 24
$505.7M
Q3 24
$478.3M
Q2 24
$485.1M
Q1 24
$472.8M
Stockholders' Equity
CMCT
CMCT
DTIL
DTIL
Q4 25
$265.4M
$92.2M
Q3 25
$281.9M
$16.6M
Q2 25
$287.1M
$34.1M
Q1 25
$293.0M
$49.3M
Q4 24
$304.5M
$56.4M
Q3 24
$321.0M
$64.9M
Q2 24
$351.1M
$74.7M
Q1 24
$369.9M
$37.2M
Total Assets
CMCT
CMCT
DTIL
DTIL
Q4 25
$859.2M
$154.4M
Q3 25
$871.8M
$93.5M
Q2 25
$885.0M
$108.9M
Q1 25
$882.3M
$124.4M
Q4 24
$889.6M
$136.4M
Q3 24
$868.0M
$153.3M
Q2 24
$891.2M
$165.8M
Q1 24
$887.5M
$184.7M
Debt / Equity
CMCT
CMCT
DTIL
DTIL
Q4 25
1.92×
Q3 25
1.87×
Q2 25
1.87×
Q1 25
1.75×
Q4 24
1.66×
Q3 24
1.49×
Q2 24
1.38×
Q1 24
1.28×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CMCT
CMCT
DTIL
DTIL
Operating Cash FlowLast quarter
$5.8M
$-11.3M
Free Cash FlowOCF − Capex
$-11.3M
FCF MarginFCF / Revenue
-32.9%
Capex IntensityCapex / Revenue
0.1%
Cash ConversionOCF / Net Profit
-0.56×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CMCT
CMCT
DTIL
DTIL
Q4 25
$5.8M
$-11.3M
Q3 25
$3.7M
$-15.3M
Q2 25
$-2.5M
$-20.3M
Q1 25
$1.2M
$-19.1M
Q4 24
$17.0M
$-58.4M
Q3 24
$10.3M
$-5.9M
Q2 24
$3.9M
$-14.9M
Q1 24
$1.6M
$-19.0M
Free Cash Flow
CMCT
CMCT
DTIL
DTIL
Q4 25
$-11.3M
Q3 25
Q2 25
$-20.3M
Q1 25
$-19.1M
Q4 24
$-58.7M
Q3 24
$-6.0M
Q2 24
$-14.9M
Q1 24
$-19.1M
FCF Margin
CMCT
CMCT
DTIL
DTIL
Q4 25
-32.9%
Q3 25
Q2 25
-112627.8%
Q1 25
-65917.2%
Q4 24
-9199.8%
Q3 24
-1033.2%
Q2 24
-29.9%
Q1 24
-108.4%
Capex Intensity
CMCT
CMCT
DTIL
DTIL
Q4 25
0.1%
Q3 25
0.0%
Q2 25
11.1%
Q1 25
220.7%
Q4 24
39.2%
Q3 24
6.8%
Q2 24
0.1%
Q1 24
0.5%
Cash Conversion
CMCT
CMCT
DTIL
DTIL
Q4 25
-0.56×
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
-0.45×
Q1 24
-2.21×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons